Research News

Antibody against RSV helps prevent wheeze in infants

BMJ 2013; 346 doi: (Published 15 May 2013) Cite this as: BMJ 2013;346:f3089

OpenUrlCrossRefPubMedWeb of Science

Palivizumab is a monoclonal antibody directed against respiratory syncytial virus (RSV) and an effective prophylactic against severe infection in high risk infants. A new trial in preterm infants reports that the drug also helps prevent …

View Full Text

Log in

Log in through your institution


* For online subscription